IB
WST icon

Intrust Bank’s West Pharmaceutical WST Stock Holding History

Intrust Bank’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-903
Closed -$296K – 402
2024
Q4 		$296K Sell
903
-225
-20% -$70.8K 0.03% 333
2024
Q3 		$339K Sell
1,128
-123
-10% -$37.7K 0.03% 317
2024
Q2 		$412K Sell
1,251
-167
-12% -$59K 0.04% 273
2024
Q1 		$561K Sell
1,418
-68
-5% -$25.2K 0.06% 233
2023
Q4 		$523K Sell
1,486
-102
-6% -$36.1K 0.06% 238
2023
Q3 		$596K Buy
1,588
+33
+2% +$12.8K 0.08% 210
2023
Q2 		$595K Sell
1,555
-4
-0.3% -$1.43K 0.07% 215
2023
Q1 		$540K Buy
1,559
+272
+21% +$79.5K 0.07% 227
2022
Q4 		$303K Buy
+1,287
New +$305K 0.04% 305
2022
Q3 		– Sell
-777
Closed -$235K – 392
2022
Q2 		$235K Sell
777
-38
-5% -$12.4K 0.03% 337
2022
Q1 		$335K Sell
815
-12
-1% -$4.7K 0.04% 302
2021
Q4 		$388K Buy
827
+122
+17% +$52.5K 0.05% 283
2021
Q3 		$299K Sell
705
-28
-4% -$11.8K 0.04% 307
2021
Q2 		$263K Buy
+733
New +$242K 0.04% 321

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Intrust Bank's WST Position: Q1 2025 in Review

Intrust Bank sold out of West Pharmaceutical (WST) in Q1 2025, closing a stake of 903 shares — an estimated $296K sold.

Intrust Bank first reported a position in WST in Q2 2021 and held it in 14 quarters. The position peaked at $596K in Q3 2023. 713 funds tracked by Wall St. Rank hold WST as of Q1 2025.

  • Intrust Bank reported no remaining West Pharmaceutical position as of Q1 2025 after selling out during the quarter.
  • Intrust Bank sold 903 West Pharmaceutical shares in Q1 2025, an estimated $296K.
  • Intrust Bank first reported a position in West Pharmaceutical in Q2 2021 and held it in 14 quarters.
  • Intrust Bank's West Pharmaceutical position peaked at $596K in Q3 2023.
  • 713 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2025.

Based on Intrust Bank's 13F filing for Q1 2025, filed 9 May 2025.